New nasal spray administered to patients with COVID-19

  • Bona Pharma

The coronavirus pandemic has been roaring on for more than 2 years and caused a lot of pain and trouble to people all over the world. COVID-19 infection poses a serious risk to patients and people who are in intimate contact with the patients. BONA has launched a new nasal spray which can be used for formulations in preventing and treating COVID-19 infection.

BONA's new metered dose nasal spray is offered in a number of different neck options to suit, plus the sprayer can be customized with different dosages, spray patterns and droplet size distribution to suit the customer's product for the most effective administration of the formulation.

Features of BONA’s new nasal spray:

  • Modular and ergonomic design
  • 18/410, 18/415, 18DIN, 18TE, 20/410, 24/410, screw on, snap on and crimp on neck
  • Metered dose pump with various dosages from 45mcl to 200mcl
  • Optimized spray atomization systems enhance pharmaceutical solution absorbing
  • Dose uniformity tests are regularly taken.
  • Spray pattern and droplet size distribution performance can be adjusted according to different customers’ requirements.
  • Production Capacity: 1 million pcs per day
  • Comply with USP, EP food & drug direct contact regulations
  • Clean Room: Class 100,000 (Class D) according to GMP regulations
  • Lead Time: 30 days
  • Customization welcome

For further details, simply contact BONA Pharma.

See also

BONA Pharma’s disinfection topical spray pump for 100ml PET Bottle

With the COVID-19 coronavirus epidemic spreading, the World Health Organization is telling people to stay at home, wash hands frequently, and disinfect continuously. In order to help people stay stafe, BONA has launched a multi-volume liquid PET bottle with topical spray pump ideal for disinfection. Although these are difficult times, BONA wants everyone to be strong, stay safe, and act accordingly now in order to reduce the spread of the virus.

  • Jo Webb
  • Product Info
  • English
  • Created 11 May 2022
  • Modified 11 May 2022
  • Hits 330